Cargando…

Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer

BACKGROUND: To investigate the prognostic role of pretreatment squamous cell carcinoma antigen (SCCA) in early-stage cervical cancer (CC). METHODS: We enrolled 487 cases of pathology-proven early-stage [International Federation of Gynecology and Obstetrics (FIGO) I/II] squamous or adenosquamous CC t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xiao-Dan, Huo, Lan-Qing, Luo, Ying-Shan, Chen, Kai, Li, Jun-Yun, Shi, Liu, Huang, Lin, Cao, Xin-Ping, Ou-Yang, Yi, Chen, Fo-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071156/ https://www.ncbi.nlm.nih.gov/pubmed/37025259 http://dx.doi.org/10.1177/17588359231165974

Ejemplares similares

Construction of refined staging classification systems integrating FIGO/T‐categories and corpus uterine invasion for non‐metastatic cervical cancer
por: Huang, Xiao‐Dan, et al.
Publicado: (2023)

Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making
por: Shi, Liu, et al.
Publicado: (2023)

Could Adjuvant Chemotherapy Improve Prognosis for Cervical Cancer Patients with Elevated Pretreatment Serum Squamous-Cell Carcinoma Antigen?
por: Yuan, Zhen, et al.
Publicado: (2021)

The Role of Utility in Decision-Making
por: Lindley, D. V.
Publicado: (1975)

Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix
por: Huang, Eng-Yen, et al.
Publicado: (2012)

Predictive value of preoperative serum squamous cell carcinoma antigen level for lymph node metastasis in early-stage cervical squamous cell carcinoma
por: Zhu, Chenggong, et al.
Publicado: (2021)

Intermediate-stage hepatocellular carcinoma treated with hepatic resection: the NSP score as an aid to decision-making
por: Zhang, Yong-Fa, et al.
Publicado: (2016)

Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.
por: Kenter, G., et al.
Publicado: (1987)

Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinoma
por: CHEN, JUNYING, et al.
Publicado: (2013)

Predictive Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma
por: Chen, Miao-Fen, et al.
Publicado: (2018)

Effects of two genes coding squamous cell carcinoma antigen on the diagnosis and treatment of cervical squamous cell carcinoma
por: Yin, Qi’nan, et al.
Publicado: (2014)

Utilization of MRI in surgical decision making in the shoulder
por: Simon, Maciej J. K., et al.
Publicado: (2022)

Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice
por: Shimura, Kotaro, et al.
Publicado: (2013)

The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric modulated arc therapy
por: Cheng, Yuan-Kai, et al.
Publicado: (2022)

Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma
por: Huang, Hao, et al.
Publicado: (2017)

Squamous cell carcinoma antigen in cervical cancer and beyond
por: Kim, Byoung-Gie
Publicado: (2013)

Serum MicroRNAs Related with Chemoradiotherapy Resistance in Advanced-Stage Cervical Squamous Cell Carcinoma
por: Han, Ying, et al.
Publicado: (2017)

Radiomic Analysis for Pretreatment Prediction of Recurrence Post-Radiotherapy in Cervical Squamous Cell Carcinoma Cancer
por: Kawahara, Daisuke, et al.
Publicado: (2022)

Pretreatment Nomograms for Local and Regional Recurrence after Radical Radiation Therapy for Primary Nasopharyngeal Carcinoma
por: Chen, Fo-ping, et al.
Publicado: (2017)

Characteristics of brain activation in high-level football players at different stages of decision-making tasks off the ball: an fMRI study
por: Huang, Ming-Hao, et al.
Publicado: (2023)

Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making
por: Lian, Chen-Lu, et al.
Publicado: (2021)

Decision-making factors affecting different family members regarding the placement of relatives in long-term care facilities
por: Huang, Ying-Chia, et al.
Publicado: (2014)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

A novel serum microRNA signature to screen esophageal squamous cell carcinoma
por: Huang, Zebo, et al.
Publicado: (2016)

Complementary Roles of Squamous Cell Carcinoma Antigen and (18)F-FDG PET/CT in Suspected Recurrence of Cervical Squamous Cell Cancer
por: Hu, Ying-Ying, et al.
Publicado: (2015)

Subaxial Cervical Spine Trauma: Evaluation and Surgical Decision-Making
por: Joaquim, Andrei F., et al.
Publicado: (2013)

Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer
por: Markovina, Stephanie, et al.
Publicado: (2018)

Pretreatment plasma fibrinogen and serum albumin levels predict therapeutic efficacy of concurrent radiochemotherapy for esophageal squamous cell cancer
por: Wang, Jijin, et al.
Publicado: (2022)

GABAergic motor neurons bias locomotor decision-making in C. elegans
por: Liu, Ping, et al.
Publicado: (2020)

A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer
por: Tian, Xun, et al.
Publicado: (2021)

Assessment of cervical lymph node metastasis for therapeutic decision-making in squamous cell carcinoma of buccal mucosa: a prospective clinical analysis
por: Essig, Harald, et al.
Publicado: (2012)

Feasibility of using two-dimensional axial computed tomography in pretreatment decision making for patients with early gastric cancer
por: Kim, Duk Ki, et al.
Publicado: (2020)

Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis
por: Chen, Fo-Ping, et al.
Publicado: (2017)

Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma
por: Zhou, Ping, et al.
Publicado: (2021)

Pretreatment Squamous Cell Carcinoma Antigen (SCC-Ag) as a Predictive Factor for the Use of Consolidation Chemotherapy in Cervical Cancer Patients After Postoperative Extended-Field Concurrent Chemoradiotherapy
por: Zhang, Guangyu, et al.
Publicado: (2021)

Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor–positive breast cancer
por: Chen, Weilin, et al.
Publicado: (2023)

Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma
por: Chen, Peng, et al.
Publicado: (2020)

The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer
por: Fu, Jingxuan, et al.
Publicado: (2019)

Cervical spondylotic myelopathy: a review of surgical indications and decision making.
por: Law, M. D., et al.
Publicado: (1993)

Shared Decision-Making and Women’s Adherence to Breast and Cervical Cancer Screenings
por: Han, Jayoung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ndoi304gvqbo8mfa6fm1rvlc9e